Molly White currently serves as Vice President of Strategic Initiatives at Dyne Therapeutics, a clinical-stage company focused on genetically driven muscle.
Molly White currently serves as Vice President of Strategic Initiatives at Dyne Therapeutics, a clinical-stage company focused on genetically driven muscle diseases, having joined the firm in 2024. Her work supports the company's strategic efforts in advancing therapeutics for conditions like Duchenne muscular dystrophy and FSHD. She is not a founder of the company.
Full founder directory · Investor directory · Company funding database · Fundraising library
The Startup Fundraising Platform
Raise funds for your startup
Find the right investors and get real replies — instantly, powered by AI.
Takes 30 seconds · No credit card · Cancel anytime
Slide-by-slide guide